Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2016 Apr 5;14(7):1035–1043. doi: 10.1016/j.cgh.2016.03.040

Table 4.

Median time to prior authorization request completion and direct-acting antiviral prescription fill and absolute denial, overall and by type of insurance.

Median Days to Fill (IQR) P-value
Overall (n=2,321) Medicaid (n=503) Medicare (n=795) Commercial (n=1,023) Medicaid vs. Medicare Medicaid vs. Commercial
Median time to prior authorization completion (days, IQR) 9 (6 – 13) 9 (7 – 14) 9 (7 – 13) 9 (6 – 13) 0.68 0.16

Median time to prescription fill (days, IQR)
 All approved prescriptions 14 (10 – 24) 24 (13 – 49) 14 (10 – 21) 14 (9 – 22) <0.001 <0.001
 Insurer denial preceding approval of prescription fill 38 (25 – 60) 46 (32 – 68) 35 (21 – 51) 32 (25 – 59) <0.001 0.003
 Prescription fill approved without insurer denial 13 (9 – 18) 14 (8 – 21) 13 (9 – 17) 13 (9 – 19) 0.33 0.70

Median time to absolute denial (days, IQR) 15 (10 – 22) 14 (9 – 21) 11 (8 – 20) 18 (12 – 28) 0.263 0.006

Abbreviation: IQR=interquartile range